Paper15719366
Direct effects of T-bet and MHC class I expression, but not STAT1, on peripheral NK cell maturation.
Robbins SH and 3 others. Eur J Immunol, 2005. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. Direct effects of T-bet and MHC class I expression, but not STAT1, on peripheral NK cell maturation. Papers, record 15719366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15719366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA-Binding Proteins | Major topic |
| Histocompatibility Antigens Class I | Major topic |
| Killer Cells, Natural | Major topic |
| Trans-Activators | Major topic |
| Transcription Factors | Major topic |
| Animals | |
| Flow Cytometry | |
| Lectins, C-Type | |
| Male | |
| Mice | |
| Mice, Knockout | |
| Muromegalovirus | |
| Receptors, Immunologic | |
| STAT1 Transcription Factor | |
| T-Box Domain Proteins | |
| T-bet Transcription Factor |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI46709 | NIAID NIH HHS | United States | R01AI046709 | PubMed and NIH | NIH RePORTER |
| AI58181 | NIAID NIH HHS | United States | R01AI058181 | PubMed and NIH | NIH RePORTER |
| R21AI046709 | NIH | NIH RePORTER | |||
| R56AI058181 | NIH | NIH RePORTER |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41068129 | EGFR-STAT1 pathway drives fibrosis initiation in fibroinflammatory skin diseases. | Nat Commun | 2025 | https://conductscience.org/library/papers/41068129 | PubMed |
| 40298450 | The inhibitory receptor LAG3 affects NK cell IFN-γ production through glycolysis and the PSAT1/STAT1/IFNG pathway. | mBio | 2025 | https://conductscience.org/library/papers/40298450 | PubMed |
| 39963570 | STAT signaling pathways in immune cells and their associated mechanisms in cancer pathogenesis. | Bioimpacts | 2025 | https://conductscience.org/library/papers/39963570 | PubMed |
| 36911202 | JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/36911202 | PubMed |
| 35767701 | STAT1 is essential for HSC function and maintains MHCIIhi stem cells that resist myeloablation and neoplastic expansion. | Blood | 2022 | https://conductscience.org/library/papers/35767701 | PubMed |
| 34521844 | Sequential actions of EOMES and T-BET promote stepwise maturation of natural killer cells. | Nat Commun | 2021 | https://conductscience.org/library/papers/34521844 | PubMed |
| 33042133 | STAT1 Isoforms Differentially Regulate NK Cell Maturation and Anti-tumor Activity. | Front Immunol | 2020 | https://conductscience.org/library/papers/33042133 | PubMed |
| 32733432 | NK Cell Development in Times of Innate Lymphoid Cell Diversity. | Front Immunol | 2020 | https://conductscience.org/library/papers/32733432 | PubMed |
| 32560225 | Transcriptional Regulation of Natural Killer Cell Development and Functions. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32560225 | PubMed |
| 32027025 | DNA methylation-mediated Siglec-7 regulation in natural killer cells via two 5' promoter CpG sites. | Immunology | 2020 | https://conductscience.org/library/papers/32027025 | PubMed |
| 31781102 | JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation. | Front Immunol | 2019 | https://conductscience.org/library/papers/31781102 | PubMed |
| 31681330 | Transcriptional, Epigenetic and Pharmacological Control of JAK/STAT Pathway in NK Cells. | Front Immunol | 2019 | https://conductscience.org/library/papers/31681330 | PubMed |
| 30718299 | NK Cells Require Cell-Extrinsic and -Intrinsic TYK2 for Full Functionality in Tumor Surveillance and Antibacterial Immunity. | J Immunol | 2019 | https://conductscience.org/library/papers/30718299 | PubMed |
| 30294965 | JAK/STAT signaling in regulation of innate lymphoid cells: The gods before the guardians. | Immunol Rev | 2018 | https://conductscience.org/library/papers/30294965 | PubMed |
| 29692982 | Oncogenes in immune cells as potential therapeutic targets. | Immunotargets Ther | 2018 | https://conductscience.org/library/papers/29692982 | PubMed |
| 28149296 | STATs in NK-Cells: The Good, the Bad, and the Ugly. | Front Immunol | 2016 | https://conductscience.org/library/papers/28149296 | PubMed |
| 27379101 | T-bet and Eomesodermin in NK Cell Development, Maturation, and Function. | Front Immunol | 2016 | https://conductscience.org/library/papers/27379101 | PubMed |
| 26451322 | In vivo tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activity. | Oncoimmunology | 2015 | https://conductscience.org/library/papers/26451322 | PubMed |
| 26341400 | Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses. | Immunity | 2015 | https://conductscience.org/library/papers/26341400 | PubMed |
| 26232430 | Cardif (MAVS) Regulates the Maturation of NK Cells. | J Immunol | 2015 | https://conductscience.org/library/papers/26232430 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15719366
GET https://conductscience.org/api/papers/v1/15719366/cited_by?page=2